OncNGS
  • Home
  • Call for tenders (closed)
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • FAQ
  • News
  • Contact
  • Workspace
  • Home
  • Call for tenders (closed)
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • FAQ
  • News
  • Contact
  • Workspace

Melinda Leigh

Melinda Leigh
2018-01-20
by admin9173

“ Unova is a user friendly and very helpful, without expecting to get paid for it. Those are the kinds of things unova will bring you good and that people will remember when they are ready to go to the next step and need help to do it. ”

Share us on:

Articles récents

  • oncNGS final event – 10/04/2026
  • Special Communication on oncNGS PCP published in ESMO Open
  • OncNGS enters Phase 3 of the PCP with two innovative solutions for cancer NGS testing
  • oncNGS consortium conducted site visits to phase 2 contractors
  • OncNGS has entered in prototyping phase (Phase 2) with the selection of three innovative approaches for future Next-Generation Sequencing (NGS) tests for cancer

Archives

  • mars 2026
  • mai 2025
  • janvier 2025
  • mai 2024
  • septembre 2023
  • février 2023
  • juillet 2022
  • juin 2022
  • mars 2022
  • janvier 2022
  • décembre 2021
  • novembre 2021
  • septembre 2021
  • août 2021
  • juin 2021
  • mai 2021
  • avril 2021
  • mars 2021

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874467

Follow us:

© OncNGS

  • Privacy policy
  • Disclaimer